TNF-alpha variant fusion molecules
US12410223B2 · kind B2 · utility
0Cited by
27References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 8, 2024 |
| Grant date | Sep 9, 2025 |
| Priority date | — |
| Expiry date | Nov 8, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to TNF-alpha variants and TNF-alpha variant fusion molecules and therapeutic uses of such thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.